The Journal of allergy and clinical immunology
Biologics in the Treatment of Severe Asthma in Children and Adults - Updates 2024-2025.
Courtney L Gaberino, Jason Moraczewski, Daniel J Jackon, Leonard B Bacharier
Published: 202610.1016/j.jaci.2026.01.002
Abstract
The development of targeted monoclonal antibodies has transformed the treatment of moderate-to-severe asthma. The main clinical trial outcomes have focused on exacerbation reduction and lung function improvement. In the last few years, there have bee…
Preview only. Read the full abstract at the source